Clearwater Capital Advisors, LLC Pacific Biosciences Of California, Inc. Transaction History

Clearwater Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$3.52 - $9.59 $1,415 - $3,855	-402 Reduced 3.38%	11,482 $43,000
Q3 2023 Oct 24, 2023	SELL	$8.23 - $13.93 $5,102 - $8,636	-620 Reduced 4.96%	11,884 $99,000
Q4 2022 Jan 27, 2023	SELL	$5.67 - $11.2 $9,072 - $17,920	-1,600 Reduced 11.34%	12,504 $0
Q2 2022 Jul 21, 2022	BUY	$4.02 - $10.43 $3,215 - $8,344	800 Added 6.01%	14,104 $62,000
Q1 2022 May 03, 2022	BUY	$8.43 - $20.9 $24,531 - $60,818	2,910 Added 28.0%	13,304 $121,000
Q4 2021 Jan 26, 2022	BUY	$19.26 - $30.08 $26,289 - $41,059	1,365 Added 15.12%	10,394 $213,000
Q3 2021 Nov 03, 2021	BUY	$24.86 - $35.02 $30,751 - $43,319	1,237 Added 15.88%	9,029 $231,000
Q2 2021 Aug 04, 2021	BUY	$22.3 - $36.02 $8,875 - $14,335	398 Added 5.38%	7,792 $272,000
Q1 2021 Apr 21, 2021	BUY	$26.38 - $51.15 $195,053 - $378,203	7,394 New	7,394 $246,000

253

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $387M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Clearwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearwater Capital Advisors, LLC with notifications on news.